Detected ·
K2 Therapeutics
$50M—
K2 Therapeutics formally launches and appoints Ying Huang as CEO, backed by $50M in seed financing from MPM BioImpact to identify and advance transformative medicines globally.
- Website
- www.k2tx.com
- Amount
- $50 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-11 16:08:50 UTC
- Signal ID
- f6dd691d-01b5-4b93-bd41-ffb06f55fc9d
As the API returns it
{
"id": "f6dd691d-01b5-4b93-bd41-ffb06f55fc9d",
"created_at": "2026-08-11T16:08:50.401308Z",
"company_name": "K2 Therapeutics",
"company_website_url": "www.k2tx.com",
"company_linkedin_url": "https://www.linkedin.com/company/k2-therapeutics-sg",
"event_type": "funding",
"funding_amount": 50000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*K2 Therapeutics formally launches and appoints Ying Huang as CEO, backed by $50M in seed financing from MPM BioImpact to identify and advance transformative medicines globally.*"
}